Research 02/21/2023 Fighting liver cancer with cells of the innate immune system MHH gastroenterologist Dr. Bernd Heinrich is seeking new therapies against hepatocellular carcinoma (HCC), a malignant liver tumor. Read more
Research 02/16/2023 Iron deficiency in heart failure: tablet as an alternative to infusion? MHH cardiology starts the multicentre ORION HF study. She wants to find out whether a preparation in tablet form can correct iron deficiency and… Read more
Research 02/13/2023 Lower Saxony Animal Welfare Award for MHH project R2N Ministry for Food, Agriculture and Consumer Protection honours Professor Dr. André Bleich Read more
Research 02/03/2023 Search for alternatives to animal testing in research continues to be promoted A research association led by the MHH is developing chip-based replacement and supplementary methods to avoid animal experiments. To this end, it is… Read more
Research 01/30/2023 The key to hearing development In our inner ear, there are two different types of sensory cells that are responsible for hearing. An MHH research team has now identified the… Read more
Research 01/24/2023 Exploring the role of organ and immune ageing in heart and lung diseases Cardiovascular and pulmonary diseases are closely linked. Researchers at the MHH now want to demonstrate the molecular mechanisms and investigate the… Read more
Research 01/05/2023 How COVID-19 permanently damages the heart MHH research team shows for the first time how the inflammation in COVID 19 alters the smallest vessels in the heart. Read more
Research 12/12/2022 Progress in the fight against bile duct cancer and gallbladder cancer International expert committee led by Professor Arndt Vogel updates ESMO treatment guidelines for biliary tract cancer Read more
Research 12/09/2022 MHH: Immune booster helps with viral respiratory diseases Centre for Clinical Studies (ZKS) brings findings from science into practical application Read more
Research 12/08/2022 Using immune cells to develop new active substances and improve the efficacy and safety of drugs MHH researcher Professor Dr. Nico Lachmann receives 2.5 million euros for Fraunhofer-Attract group Read more